Literature DB >> 14769166

Mycoplasma genitalium in chronic non-gonococcal urethritis.

D Taylor-Robinson1, C B Gilroy, B J Thomas, P E Hay.   

Abstract

Seventy-eight men with a history of chronic urethritis were referred for investigation. Of 52 men diagnosed as having persistent or recurrent non-gonococcal urethritis (NGU) at the time of referral, 11 (21%) were infected with Mycoplasma genitalium and three with Chlamydia trachomatis. Men who were M. genitalium-positive had not previously received less antibiotic, in terms of treatment duration, than those who were M. genitalium-negative, suggesting a possible resistance to the antibiotics given. In the current investigation, of 11 M. genitalium-positive men with persistent or recurrent NGU who were treated for four to six weeks with erythromycin, 500 mg four times daily, nine (82%) responded clinically and microbiologically, but later six relapsed without M. genitalium being detected. The results of observing and investigating a patient for about one year, the only one to have concurrent chlamydial and mycoplasmal infections, is presented, a feature being the intermittent persistence of the mycoplasma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769166     DOI: 10.1258/095646204322637209

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  16 in total

1.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences.

Authors:  Stefanie L Iverson-Cabral; Sabina G Astete; Craig R Cohen; Eduardo P C Rocha; Patricia A Totten
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline.

Authors:  A Wikström; J S Jensen
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women.

Authors:  Emily B Hancock; Lisa E Manhart; Sara J Nelson; Roxanne Kerani; Jennifer K H Wroblewski; Patricia A Totten
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

Review 6.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

7.  Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium.

Authors:  Gwendolyn E Wood; Dorothy L Patton; Peter K Cummings; Stefanie L Iverson-Cabral; Patricia A Totten
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

8.  Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection.

Authors:  Liang Ma; Miriam Mancuso; James A Williams; Barbara Van Der Pol; J Dennis Fortenberry; Qiuyao Jia; Leann Myers; David H Martin
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

9.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

10.  Mycoplasma genitalium Nonadherent Phase Variants Arise by Multiple Mechanisms and Escape Antibody-Dependent Growth Inhibition.

Authors:  Raul Burgos; Gwendolyn E Wood; Stefanie L Iverson-Cabral; Patricia A Totten
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.